COSEE Ocean Systems: News
First-in-class cancer drug approved to fight melanoma
Description: The US Food and Drug Administration (FDA) has approved the first cancer drug to inhibit a protein - called MEK - that acts in a pathway that fuels tumour growth. The drug, called Mekinist (trametinib), was approved for use in advanced melanomas with specific mutations. Other MEK-targeting drugs are being studied in a wide range of tumours, including lung and thyroid cancers. [Source: Nature News Blog]
URL: http://blogs.nature.com/news/2013/05/first-in-class-cancer-drug-approved-to-fight-melanoma.html
Availability: Full Text
Source: Nature News Blog
Publish Date: 5/30/2013
Reading Level: Basic
Page Length:  

<< BACK